The health secretary Wes Streeting has issued a direct appeal to newly qualified doctors, urging them to refrain from joining strike action orchestrated by the British Medical Association. Writing in
NHS4- Page
148Articles
The United Kingdom stands on the threshold of a radical transformation in obesity treatment, as Eli Lilly prepares to introduce a daily weight-loss pill, Orforglipron, in 2026, once regulatory approval
New data from NHS England reveals that specialist artificial intelligence (AI) technology is transforming outcomes for stroke patients, tripling the likelihood of making a full recovery in some cases. Since
Britain faces a growing crisis in its life sciences sector as a senior executive at Novartis has declared the UK “uninvestable” owing to stringent and outdated drug pricing policies. Johan
Eli Lilly, one of the world’s largest pharmaceutical companies, has temporarily halted orders of its highly sought-after weight-loss injection, Mounjaro, to the UK. This move comes as the market braces
Wes Streeting, the new health secretary, has escalated his confrontation with leading pharmaceutical firms over the soaring cost of medicines and its impact on the UK’s broader life sciences sector.
Weight loss medications, specifically GLP1 agonists like Ozempic Wegovy and Mounjaro, are redefining the landscape of healthcare in Britain, with new research signposting not only longer lives for millions but
Labour is preparing to reignite public private partnerships (PPPs) as a solution for delivering new neighbourhood health centres central to its ambitious 10year NHS plan. Ministers are set to make
The UK market for prescription weight loss injections has witnessed dramatic upheaval, prompted by a sharp price increase for Mounjaro, currently the nation’s most widely used weight loss jab. From
A major rise in the cost of Mounjaro is set to impact more than a million weight loss patients across Britain next month amid an international dispute over medicine prices.
Shareholders of Assura, a leading landlord to the NHS, have voted decisively to merge with Primary Health Properties (PHP) rather than accept a £1.7 billion all-cash takeover from American private
Profits at Bupa the UK’s most recognised private healthcare provider have surged by nearly a fifth as growing numbers of patients look beyond the NHS due to record waiting times
A breakthrough in the battle against Alzheimer’s disease may be on the horizon after promising trial results revealed the potential of an innovative drug developed by Roche. Trontinemab has delivered
Britain’s health service faces the prospect of further disruption as nurses are expected to overwhelmingly reject a 36 per cent pay rise offered by ministers. With the Royal College of
The looming five day walkout by junior doctors threatens to push the NHS into crisis as hospitals brace for the mass cancellation of operations and critical strain on medical services.
The impending strike by resident doctors in the NHS is set to take place from 7am on Friday 25 July to 7am on Wednesday 30 July 2025. This strike follows
